JP2024540937A5 - - Google Patents
Info
- Publication number
- JP2024540937A5 JP2024540937A5 JP2024523615A JP2024523615A JP2024540937A5 JP 2024540937 A5 JP2024540937 A5 JP 2024540937A5 JP 2024523615 A JP2024523615 A JP 2024523615A JP 2024523615 A JP2024523615 A JP 2024523615A JP 2024540937 A5 JP2024540937 A5 JP 2024540937A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- lpa
- pharmaceutically acceptable
- disease
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/125409 | 2021-10-21 | ||
| PCT/CN2021/125409 WO2022083703A1 (en) | 2020-10-22 | 2021-10-21 | Compounds and compositions for treating conditions associated with lpa receptor activity |
| CNPCT/CN2022/082072 | 2022-03-21 | ||
| CN2022082072 | 2022-03-21 | ||
| PCT/CN2022/126596 WO2023066359A1 (en) | 2021-10-21 | 2022-10-21 | Compounds and compositions for treating conditions associated with lpa receptor activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540937A JP2024540937A (ja) | 2024-11-06 |
| JP2024540937A5 true JP2024540937A5 (https=) | 2025-10-27 |
Family
ID=86057939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523615A Pending JP2024540937A (ja) | 2021-10-21 | 2022-10-21 | Ｌｐａ受容体活性に関連する状態を処置するための化合物および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240400562A1 (https=) |
| EP (1) | EP4419509A4 (https=) |
| JP (1) | JP2024540937A (https=) |
| CN (1) | CN118339149A (https=) |
| WO (1) | WO2023066359A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202342017A (zh) | 2022-02-25 | 2023-11-01 | 美商洛子峰生物有限公司 | 用於治療與ｌｐａ受體活性相關的病狀的化合物及組合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820682B2 (en) * | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| AR108838A1 (es) * | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa |
| KR102623218B1 (ko) * | 2018-08-23 | 2024-01-11 | 가천대학교 산학협력단 | 페닐아세트산 유도체 및 이를 유효성분으로 함유하는 자가면역질환 예방 또는 치료용 조성물 |
| EP4058144A1 (en) * | 2019-11-15 | 2022-09-21 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof |
| CN116583501A (zh) * | 2020-10-22 | 2023-08-11 | 罗特斯生物公司 | 用于治疗与lpa受体活性相关的病症的化合物和组合物 |
-
2022
- 2022-10-21 EP EP22882964.4A patent/EP4419509A4/en active Pending
- 2022-10-21 CN CN202280079337.9A patent/CN118339149A/zh active Pending
- 2022-10-21 WO PCT/CN2022/126596 patent/WO2023066359A1/en not_active Ceased
- 2022-10-21 JP JP2024523615A patent/JP2024540937A/ja active Pending
- 2022-10-21 US US18/701,565 patent/US20240400562A1/en active Pending